Aspen Aerogels director receives RSUs and options
ASPEN AEROGELS INC director equity grant: Non-employee director Kathleen Kool received 10,370 Restricted Stock Units (RSUs) and options for 8,706 shares of Common Stock as part of her annual equity compensation.
Rhea-AI Filing Summary
ASPEN AEROGELS INC director equity grant: Non-employee director Kathleen Kool received 10,370 Restricted Stock Units (RSUs) and options for 8,706 shares of Common Stock as part of her annual equity compensation. The RSUs and options will vest on the earlier of May 13, 2027 or the day before the company’s 2027 annual stockholders meeting. Following the RSU grant, she holds 34,323 shares of Common Stock in total, including 23,953 actual shares and 10,370 RSUs, and 8,706 stock options with a $5.40 exercise price expiring in 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 19,076 shares
Grant/Award
2 txns
Insider
Kool Kathleen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 8,706 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,370 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 8,706 contracts (Direct);
Common Stock — 34,323 shares (Direct)
Footnotes (3)
- F1. The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027.
- F2. Represents 23,953 shares of Common Stock and 10,370 RSUs.
- F3. The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027.
Key Figures
RSUs granted: 10,370 RSUs
Options granted: 8,706 options
Option exercise price: $5.40 per share
+5 more
8 metrics
RSUs granted
10,370 RSUs
Annual equity grant for non-employee director on May 13, 2026
Options granted
8,706 options
Stock options granted to director on May 13, 2026
Option exercise price
$5.40 per share
Exercise price for 8,706 stock options
Options expiration
May 13, 2036
Expiration date of granted stock options
Total common shares after grant
34,323 shares
Includes 23,953 shares and 10,370 RSUs after RSU grant
Common shares held
23,953 shares
Actual Common Stock held, excluding RSUs, after grant
RSUs component of holdings
10,370 RSUs
Part of 34,323 total Common Stock-related holdings
Vesting date
Earlier of May 13, 2027 or day before 2027 meeting
Vesting trigger for RSUs and options
Key Terms
Restricted Stock Units ("RSUs"), Non-Employee Director Compensation Policy, Common Stock, stock options, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Employee Director Compensation Policy financial
"…annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy."
Common Stock financial
"Each RSU represents the right to receive one share of Common Stock upon vesting."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
stock options financial
"The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director…"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
annual meeting of stockholders financial
"…the day prior to the Issuer's annual meeting of stockholders to be held in 2027."
FAQ
What insider transaction did ASPN director Kathleen Kool report on this Form 4?
Kathleen Kool reported equity compensation grants, not market trades. She received 10,370 RSUs and 8,706 stock options for service as a non-employee director, all under Aspen Aerogels’ Non-Employee Director Compensation Policy, with no cash purchase or open-market sale involved.
How many Aspen Aerogels (ASPN) RSUs were granted to director Kathleen Kool?
She was granted 10,370 Restricted Stock Units. Each RSU represents the right to receive one share of Aspen Aerogels Common Stock upon vesting, forming part of her annual equity award for serving as a non-employee director under the company’s director compensation policy.
What stock options did Kathleen Kool receive from Aspen Aerogels (ASPN)?
She received options for 8,706 shares of Common Stock. These options have a $5.40 exercise price and will vest on the earlier of May 13, 2027 or the day before Aspen Aerogels’ 2027 annual stockholders meeting, with an expiration date in 2036.
When do Kathleen Kool’s new ASPN RSUs and options vest?
Both the RSUs and options vest on the earlier of May 13, 2027, or the day prior to Aspen Aerogels’ annual meeting of stockholders to be held in 2027. This aligns the vesting schedule with the board’s annual service cycle for non-employee directors.
Was the Aspen Aerogels (ASPN) Form 4 a stock purchase or sale by Kathleen Kool?
No, it reflects compensation, not a purchase or sale. The Form 4 reports grants of RSUs and stock options awarded under Aspen Aerogels’ Non-Employee Director Compensation Policy, with no open-market buying or selling of shares by the director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
